Search
for

    Learn

    5 / 63 results

      learn Ketoconazole

      antifungal with some anti-androgenic benefits, often used as a shampoo

      learn KY19382

      compound that activates Wnt/β-catenin to promote hair regrowth and create new hair follicles

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Starting ketoconzole. How much and How many times a week?

      in Ketoconazole  12 upvotes 9 months ago
      A user is experiencing severe dandruff and hair loss, considering using ketoconazole shampoo 2% to manage these issues. They seek advice on application frequency and effectiveness, with suggestions to use it 2-3 times a week and to consider other treatments like finasteride for hair loss.

      community Is Keto shampoo 2% even worth starting?

      in Ketoconazole  48 upvotes 11 months ago
      Ketoconazole shampoo is primarily for scalp health and reducing inflammation, not hair regrowth. Combining ketoconazole with finasteride can yield similar results to using minoxidil and finasteride together.

      community Killing the Norwood Reaper, a Journey

      in Progress Pictures  366 upvotes 1 year ago
      The user is treating hair loss with a regimen including Dutasteride, oral and topical Minoxidil, microneedling, and various supplements for overall health. They are considering adding tretinoin, stemoxydine/RU, DIM, Boron, and Fadogia Agretis to their routine.

      community KX-826 users: 0.5% vs 0.9% vs foam

      in Technology  7 upvotes 1 week ago
      KX-826 is being discussed for hair loss treatment, with users debating between 0.5% and 0.9% solutions and foam. Some report side effects like headaches, while others see no changes; it blocks androgen receptors without reducing DHT levels.

      community KX-826 1% Phase II Results from China Just Dropped

      in Research/Science  32 upvotes 2 weeks ago
      KX-826 (Pyrilutamide) 0.5% and 1.0% solutions showed promising results in increasing hair count for male androgenetic alopecia, with the 0.5% dose slightly outperforming the 1% dose. The treatment was well-tolerated with no sexual side effects, but skepticism remains due to past inconsistencies in trial results.